Dr. Anees Quyyumi, MD

Dr. Quyyumi practices at Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University.

Dr. Quyyumi's NPI, 1770594590, was assigned on August 10, 2006. Dr. Quyyumi holds Georgia license 050669.

Dr. Quyyumi's primary practice is Emory University Hospital Midtown, at 550 Peachtree Street, NE, Atlanta, GA 30308 in Fulton County. The practice phone is (404) 686-2450.

Dr. Quyyumi's primary practice is Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University. Dr. Quyyumi is also affiliated with Emory University Hospital. The medical group on file is Emory Clinic. Dmand AI also links Dr. Quyyumi to 3 more hospitals, 1 clinical lab and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Quyyumi practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Quyyumi's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Quyyumi is licensed in Georgia.

CMS data shows 729 Medicare services from Dr. Quyyumi across 7 procedure codes in 2024, for 287 Medicare patients. Medicare paid $61,354 for them.

CMS counts 287 Medicare patients who saw Dr. Quyyumi in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 25% are also on Medicaid. Their average risk score is 4.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Quyyumi's median patient age at 72, with 51% women.

In 2024, Dr. Quyyumi wrote 1,872 Medicare Part D claims for 289 patients. 94% of them were for generic drugs. CMS names the drug for 1,662 of them, across 33 drugs with 11 or more claims each, at $122,896 in total drug cost. In 2023, CMS named 1,411 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Quyyumi for performance year 2024, reported through an alternative payment model (APM). Dr. Quyyumi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Quyyumi as offering telehealth.

CMS Open Payments shows 28 general payments to Dr. Quyyumi from 3 drug and device companies from 2016 to 2025. Education make up the largest share, 52% of the total. Travere Therapeutics, Inc. paid the most, $116.